Vomiting News and Research

RSS

Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.

Real-world data reveals higher reported GLP-1 side effects in female patients

The second of a Series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health discusses the wide-ranging issues relating to use of GLP-1 RA drug use in women.

1 Oct 2026

Petrelintide produces double-digit weight loss with fewer side effects

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Diabetes & Endocrinology shows that weekly injections with the new amylin-based obesity drug petrelintide can enable those treated to lose more than 10% of their body weight – generally lower than existing incretin-based (GLP-1 RA) drugs, but also with far fewer side effects.

29 Sep 2026

Veterinary sedative in fentanyl supply spikes severe withdrawal cases

A powerful veterinary sedative, medetomidine, is increasingly infiltrating the street supplies of the already deadly opioid fentanyl, with patients suffering from its withdrawal quadrupling in recent years, according to a new analysis by researchers at the Perelman School of Medicine at the University of Pennsylvania.

29 Sep 2026

Nasal spray offers needle-free pain relief for children with injuries

A treatment for pain, that is delivered via a nasal spray, offers an effective, needle-free option for children being seen in the emergency department for a range of injuries, according to research presented at the European Emergency Medicine Congress today (Sunday).

27 Sep 2026

Common anti-epileptic medication shows promise in reducing migraine aura

A new study by researchers at Lund University in Sweden found that 85 percent of patients with aura-dominant migraine experienced a reduction in monthly aura days by at least half following treatment with the anti-epileptic drug lamotrigine.

25 Sep 2026

Mifepristone offers effective emergency contraception with fewer side effects

Emergency contraception containing mifepristone prevents more pregnancies with fewer side effects than some other common emergency contraceptive pills such as levonorgestrel, according to a new Cochrane review involving 87 trials.

20 Sep 2026

Women with hyperemesis gravidarum report major gaps in care

Medical assistance can help women suffering from severe nausea and vomiting during pregnancy, but insufficient recognition of Hyperemesis gravidarum (HG) means that many are not getting the help they need to overcome this severe and debilitating form of morning sickness.

17 Sep 2026

FDA outlines key tips for safe tampon usage

If you use tampons during your period, it's important to know how to use them safely, and to understand how the U.S. Food and Drug Administration evaluates their safety and effectiveness.

15 Sep 2026

AI identifies hidden biological patterns to accurately diagnose migraines

AI can trawl vast amounts of health data which is not specifically related to migraines, but which can be used to identify people predisposed to the condition.

11 Sep 2026

Daraxonrasib shows durable responses in RAS-mutant lung cancer

Daraxonrasib, an oral RAS inhibitor therapy, achieved durable responses in pretreated patients with RAS-mutant non-small cell lung cancer (NSCLC) in a Phase 1/2 trial led by The University of Texas MD Anderson Cancer Center.

2 Sep 2026

GLP-1 drugs have benefits beyond weight loss. Could microdoses preserve them?

A narrative review suggests GLP-1-based therapies deliver metabolic, cardiovascular, renal, and other systemic benefits, raising interest in whether lower fractional doses could improve tolerability and treatment continuity. However, direct evidence for GLP-1 microdosing remains extremely limited, and researchers say prospective studies are needed to determine whether lower doses preserve long-term benefits.

1 Sep 2026

Poison control calls could prevent many unnecessary pediatric ER visits

About 65% of young children brought to New Jersey emergency departments for suspected poisoning probably didn't need emergency care and could have stayed home if their families had called poison control before rushing to the hospital, according to Rutgers researchers.

27 Aug 2026

Understanding opioid risks can help prevent accidental overdoses

According to numbers calculated from the CDC, approximately 80,000 people died last year from a drug overdose, which represents about 21 deaths per 100,000 residents in the U.S. alone. Overdose deaths are preventable, and in most of the cases we see, they are completely accidental.

24 Aug 2026

Multiple long-term conditions raise pregnancy risks, study finds

Women who begin pregnancy with two or more pre-existing, long-term physical or mental health conditions have 20% higher risk of miscarriage, 69% higher risk of severe nausea and vomiting, and around four times the risk of anxiety and depression, compared with those with no long-term conditions.

18 Aug 2026

Pregnant women use Reddit to seek Tdap vaccine reassurance

An analysis of Reddit posts about the maternal Tdap vaccine made by pregnant women reveals expectant mothers turning to Reddit to seek advice and reassurance-with fewer outright instances of vaccine hesitation/refusal than has generally been observed for other types of vaccines, according to a study published on August 12, 2026 in the open access journal PLOS Global Public Health by Soojung Jo from Purdue University, United States, and colleagues.

12 Aug 2026

Cannabis compounds may weaken glioblastoma response to chemotherapy and radiation

Several cannabinoids reduced chemotherapy- and radiation-induced apoptosis in glioblastoma cell models, with effects linked to reduced apoptotic priming, increased pro-survival signaling, and G1 cell-cycle arrest. The findings raise concern that cannabinoid exposure could interfere with some cancer treatments, although the results are limited to laboratory models and require in vivo and clinical validation.

12 Aug 2026

Limited PBS coverage widens pregnancy nausea treatment disparities in Australia

Pregnant women in Australia are facing an unfair two-tiered system for managing morning sickness, with financial status impacting who can access the full range of modern anti-nausea medications available, rather than simply clinical need.

5 Aug 2026

Researchers identify immune cell receptor that drives organ aging process

We may age at different rates, but none of us escapes aging. A study in mice and in human cells by Stanford Medicine researchers pins much of the blame on a particular type of immune cell's increased inability, with advancing age, to gobble up another immune cell type.

16 Jul 2026

Robot-guided surgery successfully drains multiple deep brain abscesses

Brain abscesses located deep within the brain can rapidly become life-threatening and are often difficult to treat through conventional surgery. Brain abscesses located deep within the brain can rapidly become life-threatening and are often difficult to treat through conventional surgery.

13 Jul 2026

Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populations

A network meta-analysis of nine randomized controlled trials found that once-weekly semaglutide showed the largest estimated weight-loss effect among GLP-1 receptor agonists tested in adults with mental illness and obesity or related metabolic risk. The authors cautioned that the findings remain preliminary because the evidence base was small, heterogeneous, and largely indirect.

9 Jul 2026